Feb 14 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2024 Dec 31, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.61 8.64 12.65
(-0.3 pct) (-1.1 pct) (+2.6 pct)
Operating 221 mln loss 573 mln 410 mln
Recurring 236 mln loss 573 mln 400 mln
Net 220 mln loss 912 mln 400 mln
EPS 58.42 yen loss 241.17 yen 105.77 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T